Medical device startup Foundry Innovation & Research, also known as Fire1, has secured $7.5m in a round backed by existing investor Medtronic.

Allianz spinout Idinvest contributed to a series B round that will help the UK-based background checking service expand in the US.

Allianz spinout Idinvest contributed to a series B round that will help the UK-based background checking service expand in the US.

Eye disease therapy developer GenSight Biologics, which had raised almost $78m from investors including Novartis, has withdrawn an IPO expected to raise up to $70m.

In the second part of our series, editor Thierry Heles takes a closer look at how Birmingham University is building a complete ecosystem for spinouts, startups and late-stage companies.

Medical device startup Foundry Innovation & Research, also known as Fire1, has secured $7.5m in a round backed by existing investor Medtronic.

Manchester University has licensed optogenetic gene therapy to Acucela to develop possible treatments for diseases such as Retinitis Pohmentosa, which causes gradual loss of sight.

North West Fund for Venture Capital backs Traffic Observation via Management, a cybersecurity spinout from Liverpool University that is based on initial research from Queen's University.